Instead of wasting money on aducanumab, pay for programs proven to help people living with dementia

J Am Geriatr Soc. 2021 Dec;69(12):3690-3692. doi: 10.1111/jgs.17462. Epub 2021 Sep 16.

Authors

Lauren J Hunt^{1

2}, Krista L Harrison^{2

3

4}, Kenneth E Covinsky⁴

Affiliations

¹ Department of Physiological Nursing, University of California, San Francisco, San Francisco, California, USA.
² Global Brain Health Institute, University of California, San Francisco, San Francisco, California, USA.
³ Division of Geriatrics, University of California, San Francisco, San Francisco, California, USA.
⁴ Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Alzheimer Disease / economics*
Antibodies, Monoclonal, Humanized / economics*
Community Health Services / economics*
Dementia / economics*
Financial Support*
Humans
Palliative Care / economics
Value-Based Purchasing / economics

Substances

Antibodies, Monoclonal, Humanized
aducanumab

Grants and funding